Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Recurrence × pazopanib × Clear all

Phase

Phase 2 6 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 13 Sarcoma 10 Neoplasms 10 Breast Neoplasms 8 Neoplasm Metastasis 7 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 3 Colorectal Neoplasms 3 Advanced Cancers 3 Thyroid Neoplasms 2 Solid Tumors 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Liver Neoplasms 2 Kidney Neoplasms 2 Head and Neck Neoplasms 2 Wilms Tumor 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Unspecified Adult Solid Tumor - Protocol Specific 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumours 1 Solid Neoplasm 1 Recurrence 1 Osteosarcoma 1 Optic Nerve Glioma 1 Neuroblastoma 1 Lymphoma 1

Interventions

Cyclophosphamide 41 fludarabine 31 Dexamethasone 27 venetoclax 24 Cytarabine 22 Rituximab 16 pembrolizumab 14 fludarabine phosphate 14 Filgrastim 12 Etoposide 12 Lenalidomide 11 Vincristine 10 Gemcitabine 10 Azacitidine 10 pomalidomide 9 Nivolumab 9 Interleukin-2 9 Granulocyte Colony-Stimulating Factor 9 Doxorubicin 9 Calcium Dobesilate 9 carfilzomib 8 Topotecan 8 Methotrexate 8 Everolimus 8 Decitabine 8 Bortezomib 8 Melphalan 7 Cisplatin 7 Vorinostat 6 Injections 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01165385 2014-11-17

PACIFIK

UNICANCER

Phase 1 Completed

Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡